Stock Quality:
Last 7 days
1.4%
Last 30 days
-34.2%
Last 90 days
208.9%
Trailing 12 Months
0.8%
FBRX RSI Chart
Growth
Profitability
Size
Dilution Risk
Balance Sheet
Momentum
Funds Popularity
Insider Trading
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2020 | 0 | 0 | 0 | 0 |
2019 | 13.5M | 9.0M | 4.5M | 36.0K |
2018 | 438.0K | 666.0K | 18.7M | 18.0M |
2017 | 76.8K | 104.5K | 132.3K | 160.0K |
2016 | 106.8K | 87.5K | 68.3K | 49.0K |
2015 | 0 | 0 | 0 | 126.0K |
CEO | Dr. Paul A. Wagner Ph.D. |
---|---|
WEBSITE | fortebiorx.com |
SECTOR | Healthcare |
INDUSTRY | Biotechnology |
EMPLOYEES | 7 |